There is a new Phase 3 Clinical that is currently recruiting MDS patients, take a look at the info below if you’re interested. For more info and resources about MDS check out The MDS Foundation.
Primary Endpoint: Overall survival
• in the intention-to-treat population, or
• in the subgroup with very high risk per the Revised International Prognosis Scoring System (VHR-IPSS-R)
International Trial:
• More than 100 trial sites
For additional information on this study, please call the INSPIRE help line at 1-267-759-3676 or visit www.clinicaltrials.gov, identifier: NCT02562443
